The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry Jakub Gregor; Yochai Adir; Martina ¿terclová; Nesrin Mogulkoc; Mordechai R. Kramer; Martina Doubková; Martina Pla¿ková; Veronika Müller; Michael Studnicka; Monika ¿urková; Ladislav Lacina; Katarzyna Lewandowska; Vladimír Barto¿; Petra Ovesná; Ond¿ej Májek; Martina Koziar Va¿áková;

Risk Factors for Acute Exacerbations of Fibrotic Hypersensitivity Pneumonitis¿Is Exposure a Trigger That We¿re Missing? David Barros Coelho; Vanessa Santos; André Terras Alexandre; Helder Novais e Bastos; Patrícia Caetano Mota; António Morais; Natália Melo;

Novedades diagnósticas y terapéuticas en fibrosis pulmonar progresiva María Molina-Molina; Ivette Buendia-Roldan; Diego Castillo; Fabian Caro; Claudia Valenzuela; Moisés Selman;